AIM ImmunoTech Inc is trading at $0.77 (7.2% down) in after-hours trading as the stock enters a sharp giveback phase following a recent speculative surge.
- The decline extends a 7.8% drop from the previous session, where shares fell from $0.90 to $0.83.
- Shares recently soared 120% on June 1 following enthusiasm surrounding a pancreatic cancer trial enrollment milestone.
- The current volatility is driven by traders taking profits in the absence of a new follow-up catalyst to sustain the initial price spike.